{
    "2018-05-17": [
        [
            {
                "time": "",
                "original_text": "郑眼看盘：医药股调整 这几大风向标要留意",
                "features": {
                    "keywords": [
                        "医药股",
                        "调整",
                        "风向标"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "你敢信？这些股票已默默大涨超50% 这个行业成为慢牛集中营",
                "features": {
                    "keywords": [
                        "股票",
                        "大涨",
                        "行业",
                        "慢牛"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "未明确"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "秦洪看盘｜忽略A股市场短线干扰因素，布局长线确定性品种",
                "features": {
                    "keywords": [
                        "A股",
                        "短线",
                        "干扰因素",
                        "长线",
                        "确定性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "未明确"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "正大天晴16个过亿产品还不够 重磅肺癌新药来了",
                "features": {
                    "keywords": [
                        "正大天晴",
                        "过亿产品",
                        "肺癌新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "这家知名药企——江中药业，要卖给华润医药",
                "features": {
                    "keywords": [
                        "江中药业",
                        "华润医药",
                        "收购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "SGLT-2抑制剂：口服降糖药的后起之秀",
                "features": {
                    "keywords": [
                        "SGLT-2抑制剂",
                        "口服降糖药",
                        "后起之秀"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德市值超过华大基因 赶上恒瑞医药需N个一字板",
                "features": {
                    "keywords": [
                        "药明康德",
                        "华大基因",
                        "恒瑞医药",
                        "市值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "政策“吹暖”医药股 医药基金该怎么选？",
                "features": {
                    "keywords": [
                        "政策",
                        "吹暖",
                        "医药股",
                        "医药基金"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药上市18年股价翻93倍 2595亿登顶A股医药一哥",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "上市",
                        "股价",
                        "翻倍",
                        "A股医药一哥"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}